Positive Phase 2a stroke clinical data published ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, is pleased to announce the publication in a peer reviewed journal of positive clinical data from the PISCES II Phase 2a...
There may be hope for an effective plant-based treatment for various head and neck cancers, according to a new study conducted by researchers at UCLA. The organization posted an update to its findings in the last week, which aims to treat the 650,000 cases that are...
(MENAFN – Newsfile Corp) Veritas Pharma Announces Preliminary Clinical Trial Results and the Company’s New Direction Vancouver, British Columbia–(Newsfile Corp. – February 13, 2020) – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP)...
JERSEY CITY, N.J., Feb. 13, 2020 /PRNewswire/ –SCYNEXIS, Inc., Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that it has completed patient enrollment in...
Patient #1: Enrolled in mTNBC Phase 1b/2 – Injected on 9/27/2019. CTC (circulating tumor cells) dropped to zero in two weeks on 10/11/2019. Total CTC and EMT (Epithelial Mesenchymal Transition in Tumor Metastasis) dropped to zero after about one month of...
Email
Text